188 related articles for article (PubMed ID: 29498910)
1. ACUTE PHASE REACTIONS AFTER ZOLEDRONIC ACID INFUSION: PROTECTIVE ROLE OF 25-HYDROXYVITAMIN D AND PREVIOUS ORAL BISPHOSPHONATE THERAPY.
Crotti C; Watts NB; De Santis M; Ceribelli A; Fabbriciani G; Cavaciocchi F; Marasini B; Selmi C; Massarotti M
Endocr Pract; 2018 May; 24(5):405-410. PubMed ID: 29498910
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
Popp AW; Senn R; Curkovic I; Senn C; Buffat H; Popp PF; Lippuner K
Osteoporos Int; 2017 Jun; 28(6):1995-2002. PubMed ID: 28299378
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion.
Bertoldo F; Pancheri S; Zenari S; Boldini S; Giovanazzi B; Zanatta M; Valenti MT; Dalle Carbonare L; Lo Cascio V
J Bone Miner Res; 2010 Mar; 25(3):447-54. PubMed ID: 20200999
[TBL] [Abstract][Full Text] [Related]
4. Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease.
Merlotti D; Rendina D; Muscariello R; Picchioni T; Alessandri M; De Filippo G; Materozzi M; Bianciardi S; Franci MB; Lucani B; Cenci S; Strazzullo P; Nuti R; Gennari L
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31634910
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis.
Ding Y; Zeng JC; Yin F; Zhang CL; Zhang Y; Li SX; Liu X; Zhang C; Xue QY; Lin H; Pei FX
Orthop Surg; 2017 Aug; 9(3):284-289. PubMed ID: 28960821
[TBL] [Abstract][Full Text] [Related]
6. Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
Sieber P; Lardelli P; Kraenzlin CA; Kraenzlin ME; Meier C
Clin Drug Investig; 2013 Feb; 33(2):117-22. PubMed ID: 23184667
[TBL] [Abstract][Full Text] [Related]
7. Characterization of and risk factors for the acute-phase response after zoledronic acid.
Reid IR; Gamble GD; Mesenbrink P; Lakatos P; Black DM
J Clin Endocrinol Metab; 2010 Sep; 95(9):4380-7. PubMed ID: 20554708
[TBL] [Abstract][Full Text] [Related]
8. Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass.
Anastasilakis AD; Polyzos SA; Makras P; Sakellariou GT; Bisbinas I; Gkiomisi A; Delaroudis S; Gerou S; Ballaouri I; Oikonomou D; Papapoulos SE
Bone; 2012 May; 50(5):1130-4. PubMed ID: 22366634
[TBL] [Abstract][Full Text] [Related]
9. Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation: the case of zoledronic acid-induced acute phase reaction.
De Santis M; Cavaciocchi F; Ceribelli A; Crotti C; Generali E; Fabbriciani G; Selmi C; Massarotti M
Lupus; 2015 Apr; 24(4-5):442-7. PubMed ID: 25801887
[TBL] [Abstract][Full Text] [Related]
10. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
Silverman SL; Kriegman A; Goncalves J; Kianifard F; Carlson T; Leary E
Osteoporos Int; 2011 Aug; 22(8):2337-45. PubMed ID: 21116816
[TBL] [Abstract][Full Text] [Related]
11. Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion.
Chen FP; Fu TS; Lin YC; Lin YJ
Osteoporos Int; 2021 Apr; 32(4):663-670. PubMed ID: 33113007
[TBL] [Abstract][Full Text] [Related]
12. Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.
Billington EO; Horne A; Gamble GD; Maslowski K; House M; Reid IR
Osteoporos Int; 2017 Jun; 28(6):1867-1874. PubMed ID: 28233020
[TBL] [Abstract][Full Text] [Related]
13. The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.
Black DM; Reid IR; Napoli N; Ewing SK; Shiraki M; Nakamura T; Takeuchi Y; Schafer AL; Kim TY; Cauley JA
J Bone Miner Res; 2022 Jan; 37(1):21-28. PubMed ID: 34585443
[TBL] [Abstract][Full Text] [Related]
14. No effect of rosuvastatin in the zoledronate-induced acute-phase response.
Makras P; Anastasilakis AD; Polyzos SA; Bisbinas I; Sakellariou GT; Papapoulos SE
Calcif Tissue Int; 2011 May; 88(5):402-8. PubMed ID: 21305270
[TBL] [Abstract][Full Text] [Related]
15. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
16. Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.
Rossini M; Adami S; Viapiana O; Ortolani R; Vella A; Fracassi E; Gatti D
J Bone Miner Res; 2012 Jan; 27(1):227-30. PubMed ID: 21956654
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis.
Catalano A; Morabito N; Atteritano M; Basile G; Cucinotta D; Lasco A
Calcif Tissue Int; 2012 Apr; 90(4):279-85. PubMed ID: 22350110
[TBL] [Abstract][Full Text] [Related]
18. The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.
Anastasilakis AD; Polyzos SA; Delaroudis S; Bisbinas I; Sakellariou GT; Gkiomisi A; Papadopoulou E; Gerou S; Makras P
Clin Endocrinol (Oxf); 2012 Dec; 77(6):816-22. PubMed ID: 22676573
[TBL] [Abstract][Full Text] [Related]
19. [Acute phase reaction following bisphosphonates.].
Tsurukami H
Clin Calcium; 2017; 27(2):213-223. PubMed ID: 28123123
[TBL] [Abstract][Full Text] [Related]
20. The impact of dietary calcium intake and vitamin D status on the effects of zoledronate.
Bourke S; Bolland MJ; Grey A; Horne AM; Wattie DJ; Wong S; Gamble GD; Reid IR
Osteoporos Int; 2013 Jan; 24(1):349-54. PubMed ID: 22893357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
